CVS241122P73000
- 0.00
- 0.000.00%
CVS Health Newsroom
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
CVS Health Price Target Lowered to $64 From $72 at Piper Sandler
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Piper Sandler lowers CVS Health's target price to $64.
Piper Sandler: Downgraded CVS Health's target price from $72 to $64, maintaining a "shareholding" rating. (Gelonghui)
CVS Health Options Spot-On: On November 25th, 84,890 Contracts Were Traded, With 645.37K Open Interest
CVS Health Price Target Raised to $80.00/Share From $73.00 by TD Cowen
S&P 500, Dow Hit Records Right After Open | Live Stock
CVS Health Is Maintained at Overweight by Piper Sandler
CVS Health Analyst Ratings
Piper Sandler Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $64
Piper Sandler Sticks to Their Buy Rating for CVS Health (CVS)
TD Cowen Maintains CVS Health(CVS.US) With Buy Rating, Raises Target Price to $80
CVS Health's Strategic Turnaround: Poised for Growth in Medicare Advantage and Market Share Gains by 2025
Express News | CVS Health Corp : Piper Sandler Cuts Target Price to $64 From $72
Palantir Price Target Raised To $75 By Dan Ives Amid 288% YTD Surge: Analyst Calls 2025 A 'Primetime' Year For AI
Pension Doubles Its Palantir Stake and Buys Up Intel and CVS. -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day